BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6652963)

  • 1. The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection.
    Nakayama S; Gewurz H; Holzer T; Du Clos TW; Mold C
    Clin Exp Immunol; 1983 Nov; 54(2):319-26. PubMed ID: 6652963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.
    Mold C; Rodic-Polic B; Du Clos TW
    J Immunol; 2002 Jun; 168(12):6375-81. PubMed ID: 12055255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide.
    Suresh MV; Singh SK; Ferguson DA; Agrawal A
    J Immunol; 2007 Jan; 178(2):1158-1163. PubMed ID: 17202380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection.
    Suresh MV; Singh SK; Ferguson DA; Agrawal A
    J Immunol; 2006 Apr; 176(7):4369-74. PubMed ID: 16547275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood clearance of Streptococcus pneumoniae by C-reactive protein.
    Horowitz J; Volanakis JE; Briles DE
    J Immunol; 1987 Apr; 138(8):2598-603. PubMed ID: 3559209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein is protective against Streptococcus pneumoniae infection in mice.
    Mold C; Nakayama S; Holzer TJ; Gewurz H; Du Clos TW
    J Exp Med; 1981 Nov; 154(5):1703-8. PubMed ID: 7299351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of C-reactive protein to the pneumococcal capsule or cell wall results in differential localization of C3 and stimulation of phagocytosis.
    Holzer TJ; Edwards KM; Gewurz H; Mold C
    J Immunol; 1984 Sep; 133(3):1424-30. PubMed ID: 6747291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.
    Gang TB; Hanley GA; Agrawal A
    Infect Immun; 2015 May; 83(5):1845-52. PubMed ID: 25690104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice.
    Szalai AJ; Briles DE; Volanakis JE
    J Immunol; 1995 Sep; 155(5):2557-63. PubMed ID: 7650385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Pneumococcal Infection by Using Engineered Human C-Reactive Protein in a Mouse Model.
    Ngwa DN; Singh SK; Gang TB; Agrawal A
    Front Immunol; 2020; 11():586669. PubMed ID: 33117400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Activation by C-Reactive Protein Is Critical for Protection of Mice Against Pneumococcal Infection.
    Singh SK; Ngwa DN; Agrawal A
    Front Immunol; 2020; 11():1812. PubMed ID: 32903624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection.
    Agrawal A; Suresh MV; Singh SK; Ferguson DA
    Endocr Metab Immune Disord Drug Targets; 2008 Dec; 8(4):231-7. PubMed ID: 19075776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection.
    Gang TB; Hammond DJ; Singh SK; Ferguson DA; Mishra VK; Agrawal A
    J Biol Chem; 2012 Dec; 287(51):43116-25. PubMed ID: 23139417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of antibody responses to phosphocholine by C-reactive protein.
    Nakayama S; Du Clos TW; Gewurz H; Mold C
    J Immunol; 1984 Mar; 132(3):1336-40. PubMed ID: 6363539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae.
    Szalai AJ; Briles DE; Volanakis JE
    Infect Immun; 1996 Nov; 64(11):4850-3. PubMed ID: 8890251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection.
    Ngwa DN; Singh SK; Agrawal A
    Front Immunol; 2020; 11():620784. PubMed ID: 33552084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against fulminant sepsis in splenectomized mice by implantation of autochthonous splenic tissue.
    Likhite VV
    Exp Hematol; 1978 May; 6(5):433-9. PubMed ID: 77790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic autotransplantation restores IL-17 production and antibody response to Streptococcus pneumoniae in splenectomized mice.
    Fernandes BF; Rezende AB; Alves CC; Teixeira FM; Farias RE; Ferreira AP; Teixeira HC
    Transpl Immunol; 2010 Feb; 22(3-4):195-7. PubMed ID: 20036332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-18 protects splenectomized mice from lethal Streptococcus pneumoniae sepsis independent of interferon-gamma by inducing IgM production.
    Kuranaga N; Kinoshita M; Kawabata T; Habu Y; Shinomiya N; Seki S
    J Infect Dis; 2006 Oct; 194(7):993-1002. PubMed ID: 16960788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice.
    Yother J; Volanakis JE; Briles DE
    J Immunol; 1982 May; 128(5):2374-6. PubMed ID: 7061864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.